Physician profile
Peter J Kauffman
NPI 1144251364
$11,715.85
in general payments reported to CMS, 2019-2025
36 companies · $3,363 in 2025
The $3,363 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,701 · 2022: $1,716 · 2023: $2,175 · 2024: $2,760 · 2025: $3,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,367 · Travel and Lodging: $732 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,366.83 |
| Travel and Lodging | $732.04 |
| Education | $199.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,673.62 | 2021-2025 | Airsupra, Fasenra, Tezspire |
| Inspire Medical Systems, INC. | $1,706.28 | 2023-2025 | Inspire |
| Glaxosmithkline, LLC. | $1,084.93 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Jazz Pharmaceuticals INC. | $882.23 | 2021-2025 | |
| Insmed, INC. | $677.66 | 2021-2025 | Arikayce, Brinsupri |
| Genzyme Corporation | $480.13 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $450.19 | 2021-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $422.49 | 2021-2025 | Ofev, Jascayd, Spiriva |
| Takeda Pharmaceuticals U.S.A., INC. | $348.70 | 2021-2025 | Glassia, Hyqvia |
| Mallinckrodt Hospital Products INC. | $297.36 | 2022-2025 | Acthar |
| Grifols USA, LLC | $294.23 | 2021-2025 | Prolastin-C Liquid, Xembify |
| Mylan Specialty L.P. | $284.68 | 2021-2024 | Yupelri |
| Lilly USA, LLC | $275.63 | 2025 | Zepbound |
| Actelion Pharmaceuticals US, INC. | $269.43 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
| Avadel Cns Pharmaceuticals, LLC | $256.20 | 2024-2025 | Lumryz |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $178.73 | 2022-2025 | Tezspire |
| Baxter Healthcare | $155.05 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Pulmonx Corporation | $125.00 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Merck Sharp & Dohme LLC | $100.61 | 2023-2025 | Winrevair, Zerbaxa, Recarbrio |
| Sanofi-Aventis U.S. LLC | $99.95 | 2025 | |
| Viatris Specialty LLC | $72.32 | 2025 | Yupelri |
| Philips North America LLC | $70.91 | 2021 | |
| Verona Pharma, INC. | $70.10 | 2025 | Ohtuvayre |
| Electromed, INC. | $66.48 | 2021 | |
| Pfizer INC. | $65.19 | 2022-2025 | |
| United Therapeutics Corporation | $61.92 | 2021-2022 | |
| Axsome Therapeutics, INC. | $59.21 | 2023-2024 | Sunosi |
| Novartis Pharmaceuticals Corporation | $42.24 | 2021 | |
| Scpharmaceuticals INC. | $23.68 | 2023 | |
| Irhythm Technologies, INC. | $21.43 | 2024 | Zio Monitor, Zio Xt Patch |
| Abbott Laboratories | $21.42 | 2025 | Cardiomems |
| Genentech USA, INC. | $18.31 | 2021 | |
| Vifor Pharma, INC. | $17.13 | 2025 | Zemaira |
| Phadia US INC. | $15.95 | 2024 | Immunocap |
| Paratek Pharmaceuticals, INC. | $14.55 | 2023 | Nuzyra |
| Teva Pharmaceuticals USA, INC. | $11.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Kauffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.